Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-09-06 00:05Core Viewpoint - The resignation of independent non-executive director Yang Yue and the subsequent nomination of Yang Jin as her replacement are aimed at maintaining the governance structure of Junshi Biosciences, ensuring compliance with legal requirements and the smooth operation of the board [1][3][5]. Group 1: Director Resignation - Yang Yue resigned from her position as an independent non-executive director and committee member due to other work commitments, effective immediately [1][2]. - Her resignation does not affect the board's minimum member count or its normal operations, and she will continue to fulfill her duties until a successor is elected [1][2]. Group 2: Appointment of New Independent Non-Executive Director - Yang Jin has been nominated as the candidate for the independent non-executive director position, pending approval at the upcoming shareholders' meeting [3][5]. - Yang Jin possesses the necessary experience and qualifications to fulfill the role, with no legal restrictions on his appointment [3][6]. Group 3: Adjustment of Board Committees - Following the resignation, the board has approved adjustments to the specialized committees, including the appointment of Yang Jin to the remuneration and assessment committee and Lu Kun to the nomination committee, effective upon shareholder approval [5][6]. Group 4: Upcoming Shareholders' Meeting - The first extraordinary shareholders' meeting of 2025 is scheduled for September 26, 2025, where the nomination of Yang Jin will be among the agenda items [7][8]. - The meeting will utilize both on-site and online voting methods, ensuring broad participation from shareholders [8][10].